CJC-1295 DAC Protocol: A Guide to Weekly Dosing for Sustained GH Release
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Explore the benefits of CJC-1295 with DAC, a long-acting GHRH analog that allows for convenient weekly dosing and sustained elevation of growth hormone levels.
CJC-1295 DAC Protocol: A Guide to Weekly Dosing for Sustained GH Release
In the realm of growth hormone secretagogues, CJC-1295 with Drug Affinity Complex (DAC) stands out for its unique pharmacokinetic profile and convenient dosing schedule. This long-acting analog of growth hormone-releasing hormone (GHRH) offers a sustained elevation of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels, making it an attractive option for those seeking the benefits of increased GH without the need for frequent injections. This article provides a comprehensive overview of the CJC-1295 DAC protocol, with a focus on its weekly dosing schedule and what the research says about its efficacy and safety.
Understanding CJC-1295 with DAC
CJC-1295 is a synthetic peptide that mimics the effects of GHRH. The addition of the Drug Affinity Complex (DAC) is what sets this version of the peptide apart. The DAC is a chemical modification that allows CJC-1295 to bind to albumin, a protein in the blood. This binding protects the peptide from rapid degradation and clearance, extending its half-life from a few minutes to several days. The result is a prolonged stimulation of the pituitary gland, leading to a sustained increase in GH and IGF-1 levels.
The Benefits of a Weekly Dosing Protocol
The extended half-life of CJC-1295 with DAC is its primary advantage. Unlike its non-DAC counterpart, which requires daily or even multiple daily injections, CJC-1295 with DAC can be administered just once or twice a week. This makes it a much more convenient and user-friendly option for long-term therapy. The sustained elevation of GH and IGF-1 levels can also lead to more consistent and pronounced benefits, which may include increased muscle mass, reduced body fat, improved recovery, and enhanced anti-aging effects.
The CJC-1295 DAC Protocol
A typical CJC-1295 DAC protocol involves the subcutaneous injection of the peptide once or twice per week. The dosage can vary depending on the individual's goals and tolerance, but a common starting dose is 500-1000 mcg per week, administered in a single injection. Some protocols may involve splitting the weekly dose into two smaller injections to maintain more stable blood levels. The duration of a CJC-1295 DAC cycle can range from 8 to 12 weeks, followed by a washout period to allow the pituitary to resensitize.
| Parameter | Typical Range | Notes |
| :--- | :--- | :--- |
| CJC-1295 DAC Dose | 500-1000 mcg | Once or twice per week |
| Administration | Subcutaneous | Rotate injection sites |
| Cycle Length | 8-12 weeks | Followed by a washout period |
| Timing | Can be taken any time of day | Does not need to be on an empty stomach |
Potential Side Effects and Considerations
While CJC-1295 with DAC is generally well-tolerated, it is not without potential side effects. The most common side effects are related to the increase in GH levels and can include water retention, joint pain, and carpal tunnel-like symptoms. These side effects are typically dose-dependent and can be managed by reducing the dosage. It is also important to be aware that the long-term effects of sustained GH elevation are not fully understood. As with any peptide therapy, it is crucial to work with a qualified healthcare provider to monitor your progress and ensure your safety.
Key Takeaways
CJC-1295 with DAC is a long-acting GHRH analog that allows for weekly dosing.
The addition of the DAC extends the half-life of the peptide, leading to a sustained increase in GH and IGF-1 levels.
A typical protocol involves weekly injections of 500-1000 mcg.
Potential side effects are generally mild and dose-dependent.
CJC-1295 with DAC offers a convenient and effective way to increase growth hormone levels.
> Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
[1] Peptide Dosages. (n.d.). CJC-1295 DAC (5 mg Vial) Dosage Protocol. Peptide Dosages. https://peptidedosages.com/single-peptide-dosages/cjc-1295-dac-5-mg-vial-dosage-protocol/
[2] Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
[3] Yunique Medical. (n.d.). CJC 1295 Peptide Guide*. Yunique Medical. https://yuniquemedical.com/cjc-1295/
---